The WHO has released new guidelines for prophylactic TB treatments. Among the updates to the guidelines are adjusted dosage recommendations and a new recommendation for a 6 month course of levofloxacin for individual exposed to TB or MDR-TB. Learn more here.
top of page
Recent Posts
See AllThe results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...
80
This month, the Indian Patent Office denied the last of the three Janssen patent extension applications for bedaquiline. While TB...
30
The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...
450
bottom of page
Commenti